Theseus Pharmaceuticals, Inc. (THRX) Social Stream
THESEUS PHARMACEUTICALS INC (THRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering THESEUS PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 4 | $28 | $23 | $25 | $3.99 | 526.57% |
| 2022-03-11 | 4 | $24 | $18 | $21.666 | $3.99 | 443.01% |
| 2022-04-01 | 4 | $25.001 | $18 | $22.5 | $3.99 | 463.91% |
| 2022-05-13 | 4 | $24 | $18 | $21.5 | $3.99 | 438.85% |
| 2022-11-03 | 4 | $24 | $18 | $21.6 | $3.99 | 441.35% |
| 2022-11-04 | 5 | $24 | $18 | $21.6 | $3.99 | 441.35% |
| 2023-03-10 | 6 | $24 | $18 | $21.666 | $3.99 | 443.01% |
| 2023-05-26 | 7 | $24 | $18 | $22.285 | $3.99 | 458.52% |
| 2023-08-10 | 2 | $23 | $3.5 | $13.25 | $3.99 | 232.08% |
| 2023-08-11 | 4 | $23 | $3.5 | $11.375 | $3.99 | 185.09% |
The Trend in the Analyst Price Target
THRX's average price target has moved down $13.62 over the prior 22 months.
Over the past 26 weeks, THRX's average upside potential has been 211.81%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-07-14 | 7 | 23 | 3.5 | 9.071 | 2.66 | 241.02% |
| 2023-08-10 | 2 | 23 | 3.5 | 13.250 | 3.27 | 305.2% |
| 2023-08-11 | 7 | 23 | 3.5 | 11.375 | 3.12 | 264.58% |
| 2023-08-11 | 5 | 23 | 3.5 | 11.375 | 3.12 | 264.58% |
| 2023-08-11 | 4 | 23 | 3.5 | 9.416 | 3.12 | 201.79% |
THRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 39 weeks, THRX's average broker recommendation rating worsened by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for THRX as an investment opportunity.
- THRX has a greater upside potential (average analyst target price relative to current price) than 1639.51% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, THESEUS PHARMACEUTICALS INC's number of analysts covering the stock is higher than 337.43% of them.
- THRX has a lower variance in analysts' estimates than -814.54% of all US stocks.
- THRX has a greater average analyst price target than 571.31% of Healthcare stocks.
Stocks similar to THESEUS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PYXS, XLO, and LIAN.
View All Top Stocks by Price Target
Is THRX a Buy, Hold or Sell? See the POWR Ratings now!